23 May 2013
Keywords: India, Pharmacovigilance, CDSCO, AIIMS, WHO
Article | 19 March 2010
Among the drugs selected to kick of India’s national pharmacovigilance program, which starts in April, are two H1N1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 March 2010
22 May 2013
© 2013 thepharmaletter.com